• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Urethral Bulking Agents for the Treatment of Urinary Incontinence: Efficacy, Safety, and Impact on the Overactive Bladder Symptoms with an Underlying Detrusor Overactivity.用于治疗尿失禁的尿道填充剂:疗效、安全性以及对伴有潜在逼尿肌过度活动的膀胱过度活动症症状的影响
J Clin Med. 2024 Sep 28;13(19):5810. doi: 10.3390/jcm13195810.
2
Effective treatment for mixed urinary incontinence with a pubovaginal sling.耻骨后阴道吊带术治疗混合性尿失禁的有效性
J Urol. 2003 Aug;170(2 Pt 1):494-7. doi: 10.1097/01.ju.0000069432.60521.6f.
3
Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up.TVT-Abbrevo 治疗压力性尿失禁的中期疗效:5 年随访时的疗效和安全性。
Medicina (Kaunas). 2022 Oct 8;58(10):1412. doi: 10.3390/medicina58101412.
4
Bladder neck incompetence could be an etiology of overactive bladder syndrome in women with stress urinary incontinence after anti-incontinence surgery: insights from transrectal sonography.经直肠超声对压力性尿失禁术后伴有急迫性尿失禁的女性膀胱颈功能不全的病因学分析
World J Urol. 2023 Nov;41(11):3083-3089. doi: 10.1007/s00345-023-04639-x. Epub 2023 Sep 29.
5
Factors predicting treatment success in mixed urinary incontinence treated with midurethral sling.预测混合性尿失禁患者行尿道中段吊带术治疗成功的相关因素。
Low Urin Tract Symptoms. 2023 Mar;15(2):50-56. doi: 10.1111/luts.12471. Epub 2022 Dec 19.
6
Mixed urinary incontinence: A prospective study on the effect of trans-obturator mid-urethral sling.混合性尿失禁:经闭孔尿道中段吊带术效果的前瞻性研究
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:64-69. doi: 10.1016/j.ejogrb.2017.12.003. Epub 2017 Dec 6.
7
Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?用于混合性尿失禁的聚丙烯酰胺水凝胶(PAHG):结果如何?
Int Urogynecol J. 2017 Nov;28(11):1657-1661. doi: 10.1007/s00192-017-3332-5. Epub 2017 Apr 17.
8
Bulking agents for the treatment of recurrent stress urinary incontinence: a suitable option?用于治疗复发性压力性尿失禁的填充剂:一个合适的选择?
Minerva Urol Nephrol. 2022 Dec;74(6):747-754. doi: 10.23736/S2724-6051.21.04269-5. Epub 2021 May 5.
9
Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.膀胱过度活动症女性单次排尿周期的动态尿动力学监测
Eur J Obstet Gynecol Reprod Biol. 2017 May;212:126-131. doi: 10.1016/j.ejogrb.2017.03.023. Epub 2017 Mar 18.
10
A Mobile App for Self-management of Urgency and Mixed Urinary Incontinence in Women: Randomized Controlled Trial.一款用于女性急迫性和混合性尿失禁自我管理的移动应用:随机对照试验。
J Med Internet Res. 2021 Apr 5;23(4):e19439. doi: 10.2196/19439.

本文引用的文献

1
Macroplastique Is a Safe and Effective Long-term Surgical Treatment for Stress Urinary Incontinence: Prospective Study with 10-Year Follow-up.宏整形术是压力性尿失禁安全有效的长期外科治疗方法:一项为期10年随访的前瞻性研究。
Eur Urol Focus. 2024 Aug 2. doi: 10.1016/j.euf.2024.07.010.
2
Management of mixed urinary incontinence: IUGA committee opinion.混合性尿失禁的管理:IUGA 委员会意见。
Int Urogynecol J. 2024 Feb;35(2):291-301. doi: 10.1007/s00192-023-05694-z. Epub 2024 Jan 22.
3
Does the Polydimethylsiloxane Urethral Injection (Macroplastique) Improve Sexual Function in Women, in Fertile Age, Affected by Stress Urinary Incontinence?聚二甲基硅氧烷尿道注射(Macroplastique)是否能改善生育期压力性尿失禁女性的性功能?
Medicina (Kaunas). 2023 Mar 15;59(3):580. doi: 10.3390/medicina59030580.
4
Up-to-Date Procedures in Female Stress Urinary Incontinence Surgery: A Concise Review on Bulking Agents Procedures.女性压力性尿失禁手术中的最新方法:填充剂手术的简明综述。
Medicina (Kaunas). 2022 Jun 8;58(6):775. doi: 10.3390/medicina58060775.
5
Urethral bulking agents for the treatment of recurrent stress urinary incontinence: A systematic review and meta-analysis.尿道填充剂治疗复发性压力性尿失禁:系统评价和荟萃分析。
Maturitas. 2022 Sep;163:28-37. doi: 10.1016/j.maturitas.2022.05.007. Epub 2022 May 26.
6
The subjective and objective very long-term outcomes of TVT in the COVID era: A 20-year follow-up.在新冠疫情时代 TVT 的主观和客观超长随访结果:20 年随访。
Int Urogynecol J. 2022 Apr;33(4):947-953. doi: 10.1007/s00192-022-05094-9. Epub 2022 Mar 1.
7
European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.欧洲泌尿外科学会女性非神经源性下尿路症状诊断与管理指南。第 1 部分:诊断、膀胱过度活动症、压力性尿失禁和混合性尿失禁。
Eur Urol. 2022 Jul;82(1):49-59. doi: 10.1016/j.eururo.2022.01.045. Epub 2022 Feb 23.
8
Bulking agents for the treatment of recurrent stress urinary incontinence: a suitable option?用于治疗复发性压力性尿失禁的填充剂:一个合适的选择?
Minerva Urol Nephrol. 2022 Dec;74(6):747-754. doi: 10.23736/S2724-6051.21.04269-5. Epub 2021 May 5.
9
Efficacy and effectiveness of bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis.膨体聚合物治疗应激性和混合性尿失禁的疗效和有效性:系统评价和荟萃分析。
Maturitas. 2020 Mar;133:13-31. doi: 10.1016/j.maturitas.2019.12.007. Epub 2019 Dec 11.
10
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.过度膀胱活跃症病理生理学的全面综述:迈向个体化治疗之路。
Eur Urol. 2019 Jun;75(6):988-1000. doi: 10.1016/j.eururo.2019.02.038. Epub 2019 Mar 26.

用于治疗尿失禁的尿道填充剂:疗效、安全性以及对伴有潜在逼尿肌过度活动的膀胱过度活动症症状的影响

Urethral Bulking Agents for the Treatment of Urinary Incontinence: Efficacy, Safety, and Impact on the Overactive Bladder Symptoms with an Underlying Detrusor Overactivity.

作者信息

Serati Maurizio, Campitiello Maria Rosaria, Torella Marco, Mesiano Giada, Scancarello Chiara, Ghezzi Fabio, Papadia Andrea, Gamarra Elena, Caccia Giorgio, Braga Andrea

机构信息

Department of Obstetrics and Gynecology, Del Ponte Hospital, University of Insubria, 21100 Varese, Italy.

Department of Obstetrics and Gynecology and Physiopathology of Human Reproduction, ASL Salerno, 84131 Salerno, Italy.

出版信息

J Clin Med. 2024 Sep 28;13(19):5810. doi: 10.3390/jcm13195810.

DOI:10.3390/jcm13195810
PMID:39407869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11476638/
Abstract

: Mixed urinary incontinence (MUI) has always represented a major therapeutic challenge and the management of this type of incontinence is often complicated by uncertain outcomes. Surgical options include interventions targeting both stress urinary incontinence (SUI) and urge urinary incontinence (UUI), although there are no international published guidelines that dictate whether it is better to start with surgical management to address the SUI or UUI component after the failure of conservative treatment. The aim of the present study is to evaluate the effectiveness of the Macroplastique (MPQ) procedure on overactive bladder (OAB) symptoms in women with MUI with a minimum follow-up of 1 year. : A retrospective analysis of prospectively collected data was performed in two tertiary reference centers. We enrolled all women complaining of symptoms of SUI and OAB, dry or wet, with a urodynamically confirmed diagnosis of MUI [urodynamic stress incontinence (USI) with detrusor overactivity (DO)], who took a previous ineffective antimuscarinic treatment and underwent the MPQ procedure. We considered as objectively cured women who did not leak urine during the stress test and with a 1 h pad-test negative, while International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), ICIQ-OAB, Patient Global Impression of Improvement (PGI-I) scale, and a Visual Analogue Scale (VAS) were used to assess subjective outcomes. : A total of forty-six patients who met the inclusion criteria and who underwent the MPQ procedure were considered for the analysis. At the 1-year mark of follow-up, 72% of patients were objectively cured at stress test and 65% were objectively cured at pad-test, while 72% of women declared themselves subjectively cured. OAB symptoms significantly improved after MPQ and a complete resolution of OAB was recorded in 35% of patients. : This study demonstrated that MPQ is a safe and effective option for the treatment of female MUI. Furthermore, MPQ significantly improves the symptoms of OAB and is able to completely cure this condition in a relevant percentage of women with MUI when pharmacological treatment fails.

摘要

混合性尿失禁(MUI)一直是一个重大的治疗挑战,这类尿失禁的管理往往因结果不确定而变得复杂。手术选择包括针对压力性尿失禁(SUI)和急迫性尿失禁(UUI)的干预措施,不过目前尚无国际上发表的指南规定在保守治疗失败后,是先通过手术治疗SUI成分还是UUI成分效果更好。本研究的目的是评估Macroplastique(MPQ)手术对MUI女性膀胱过度活动症(OAB)症状的有效性,随访时间至少为1年。

在两个三级参考中心对前瞻性收集的数据进行了回顾性分析。我们纳入了所有主诉有SUI和OAB症状(无论有无漏尿)、经尿动力学确诊为MUI[伴有逼尿肌过度活动(DO)的尿动力学压力性尿失禁(USI)]、之前接受过无效抗胆碱能治疗并接受了MPQ手术的女性。我们将在压力测试期间不漏尿且1小时护垫试验为阴性的女性视为客观治愈,同时使用国际尿失禁咨询问卷简表(ICIQ-SF)、ICIQ-OAB、患者总体改善印象(PGI-I)量表和视觉模拟量表(VAS)来评估主观结果。

共有46名符合纳入标准并接受了MPQ手术的患者被纳入分析。在随访1年时,72%的患者在压力测试中客观治愈,65%的患者在护垫试验中客观治愈,而72%的女性称自己主观治愈。MPQ术后OAB症状显著改善,35%的患者OAB症状完全缓解。

这项研究表明,MPQ是治疗女性MUI的一种安全有效的选择。此外,MPQ能显著改善OAB症状,在药物治疗失败时,能使相当比例的MUI女性完全治愈OAB。